T&R Biofab Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
88
- Stock Symbol
-
246710
- Share Price
-
$8.76
- (As of Wednesday Closing)
T&R Biofab General Information
Description
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
Contact Information
- Room 542, Smart Hub Industry-University
- Convergence Headquarters, 237, Sangidaehak
- Siheung, Gyeonggi
- South Korea
T&R Biofab Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.76 | $8.79 | $8.03 - $13.27 | $186M | 21.2M | 65.6K | -$0.60 |
T&R Biofab Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 201,819 | 178,594 | 413,135 | 98,195 |
| Revenue | 4,077 | 4,454 | 2,824 | 5,764 |
| EBITDA | (7,593) | (2,584) | (57,785) | (3,849) |
| Net Income | (12,626) | (8,000) | (61,172) | (4,747) |
| Total Assets | 54,224 | 60,129 | 80,258 | 44,463 |
| Total Debt | 18,710 | 16,689 | 12,774 | 866 |
T&R Biofab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
T&R Biofab Patents
T&R Biofab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4190281-A1 | Non-fixed type implant for craniotomy and method of manufacturing same | Pending | 03-Aug-2020 | 000000000 | |
| JP-2023536255-A | Non-fixed implant for craniotomy and method for manufacturing the same | Pending | 03-Aug-2020 | 000000000 | |
| US-20230263935-A1 | Non-fixed type implant for craniotomy and method of manufacturing same | Pending | 03-Aug-2020 | 000000000 | |
| US-D989314-S1 | Implant to be applied to craniotomy | Active | 23-Jun-2020 | 0 | |
| US-D967423-S1 | Implant to be applied to craniotomy | Active | 23-Jun-2020 | 0 |
T&R Biofab Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wonsoo Yun | Co-Founder, Chief Executive Officer & President | ||
| Shim Jinhyeong | Co-Founder & Chief Technology Officer and Technical Advisor |
T&R Biofab Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
T&R Biofab ESG
Risk Overview
Risk Rating
Updated August, 04, 2022
33.2 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,480
Rank
Percentile
Healthcare
Industry
00 of 606
Rank
Percentile
Medical Devices
Subindustry
00 of 207
Rank
Percentile
